Time-Restricted Feeding on Cardiovascular Health Effects
NCT ID: NCT06420466
Last Updated: 2024-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2024-02-01
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Randomization and Intervention Fifty eligible participants were randomly assigned to either the intervention group (n=25) or the control group (n=25). The intervention group underwent a 6-hour daily TRF from noon to 6 P.M., while the control group did not participate in TRF but maintained their usual eating patterns. No restrictions were placed on the type or quantity of food consumed by participants in either group.
Data Collection and Measures Body Composition and Anthropometry: Measurements included body mass index, body fat percentage, muscle mass, hydration levels, protein content, and visceral fat, all assessed using a bioelectrical impedance analysis scale (Mi Body Composition Scale 2 by Huami Technology). Waist circumference was manually measured by experienced nurses using a tape measure.
Blood Pressure and Heart Rate: These vital signs were monitored using an arm cuff electronic blood pressure monitor (Panasonic EW3153), with the arm positioned at heart level to ensure accuracy. Measurements were taken after at least five minutes of seated rest.
Nutritional Intake Although time-restricted feeding interventions do not usually change the content or quantity of dietary intake, the total daily intakes of energy, fat, protein, carbohydrate, cholesterol, and fibre were calculated using the Nutritionist Pro food analysis program. This was used to determine possible changes in the subjects' dietary composition as a result of the intervention.
Compliance and Ethical Considerations The study protocol was approved by the Ethics Committee of the Seventh Affiliated Hospital of Sun Yat-sen University (Shenzhen), with the approval number KY-2022-101-01. All data were handled confidentially, and measures were taken to ensure high adherence and minimal loss to follow-up.
Statistical Analysis Descriptive statistics such as range, mean, standard deviation, and percentages were used to describe the sample characteristics. To compare differences, the change from baseline levels was assessed to account for initial variability, employing an independent samples t-test for the analysis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Time Restricted Feeding on Weight Loss and Cardio-protection (TREATY Trial)
NCT03745612
Effects of Caloric Restriction and Exercise on Body Weight, Immune Function, and Intestinal Flora
NCT04275440
Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity
NCT04647149
Effect of Time-Restricted Feeding on Fat Loss and Cardiometabolic Risk Factors in Overweight Adults
NCT03459703
Intermittent Eating on Sustaining Weight-loss in Obesity
NCT05453617
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Time-restricted Feeding group
Controlling the eating time to 6 hours per day, but not being prescriptive about the quantity and content of dietary intake.
Time-restricted Feeding
Controlling the eating time to 6 hours per day, but not being prescriptive about the quantity and content of dietary intake.
Control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Time-restricted Feeding
Controlling the eating time to 6 hours per day, but not being prescriptive about the quantity and content of dietary intake.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects are male undergraduates aged 18-24 years old.
* BMI between 24 and 28.
* Normal sleep duration, usually between 7-9 hours per day.
* Stable sleep habits, typically going to bed around midnight (±1 hour).
Exclusion Criteria
* Experiencing hypoglycemic reactions during the time-limited diet program.
* Presence of metabolic diseases such as diabetes.
* Participation in high-intensity physical training for more than 5 hours per week.
* Extreme chronotypes, as indicated by scores ≤30 or ≥70 on the Morning and Evening Questionnaire Self-Assessment Scales (MEQ-SA).
* Severe weight instability, defined as weight gain or loss of more than 5 kg in the 3 months prior to the study.
* Severe food allergy or intolerance.
* Participation in another medical study within 6 months prior to the first study visit.
18 Years
24 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Seventh Affiliated Hospital of Sun Yat-sen University
OTHER
Shenzhen University
OTHER
Zhengqi Qiu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhengqi Qiu
Associate researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shenzhen university
Shenzhen, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY-2022-101-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.